{ "items": [ "\n\n
\n \n 24 March 2022\n \n
\n\n \n \n \n\n \n \n \n \n \n\n\n \n 24 March 2022\n \n
\n\n \n \n \n\n \n \n \nThe use of data, evidence and digital tools in healthcare and policy takes a major stride forward with the official launch of the Bennett Institute for Applied Data Science and appointment of Ben Goldacre as Bennett Professor of Evidence-Based Medicine.
\n \n\n\n \n 18 March 2022\n \n
\n\n \n \n \n\n \n \n \nA new genetic study of the bacteria that cause pleurisy has shown most cases involve more than one type of bacterium, and revealed which bacterial combinations cause the most serious infections.
\n \n\n\n \n 18 March 2022\n \n
\n\n \n \n \n\n \n \n \nIn the UK, every five days a baby is born with spinal muscular atrophy (SMA). Treatments are available now. If these treatments are delivered at birth, these newborns have the best chance of living long and healthy lives. If treated later, when they are identified because of the symptoms, they may survive, but with a severe disability. So, for every 5 days that a newborn screening is delayed, a baby in the UK loses the chance of a brighter future.
\n \n\n\n \n 18 March 2022\n \n
\n\n \n \n \n\n \n \n \nThe University of Oxford has become an institutional member of the UK Reproducibility Network (UKRN), a national peer-led initiative that brings together researchers and stakeholders across the sector to ensure coordination of efforts to improve the quality of research and its trustworthiness.
\n \n\n\n \n 16 March 2022\n \n
\n\n \n \n \n\n \n \n \nThe University of Oxford in collaboration with the University of Maryland School of Medicine (UMSoM) has begun recruiting for a Phase I/II trial of a new paratyphoid vaccine in human volunteers in Oxford.
\n \n\n\n \n 16 March 2022\n \n
\n\n \n \n \n\n \n \n \nProfessor Lynne Cox of the Department of Biochemistry will co-lead a new national research network focused on transforming the health of older people and boosting the economy.
\n \n\n\n \n 16 March 2022\n \n
\n\n \n \n \n\n \n \n \nResearchers from the University of Oxford have used data from UK Biobank participants to look at changes to the brain on average 4.5 months after mild SARS-CoV-2 infection.
\n \n\n\n \n 16 March 2022\n \n
\n\n \n \n \n\n \n \n \nThe University of Oxford and the Ifakara Health Institute today announced the vaccination of the first participants in a Phase Ib/II trial testing a novel rabies vaccine in human volunteers in Tanzania.
\n \n\n\n \n 16 March 2022\n \n
\n\n \n \n \n\n \n \n \nThe Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that baricitinib, an anti-inflammatory treatment normally used to treat rheumatoid arthritis, reduces the risk of death when given to hospitalised patients with severe COVID-19.
\n \n\n\n \n 11 March 2022\n \n
\n\n \n \n \n\n \n \n \nThe COVID-19 Multi-omic Blood Atlas (COMBAT) defines hallmarks of disease severity and specificity.
\n \n\n\n \n 11 March 2022\n \n
\n\n \n \n \n\n \n \n \nA new analysis from Oxford Population Health has found that pregnant women that are 30 years old or more, overweight, of mixed ethnicity or have gestational diabetes have a greater risk of contracting severe COVID-19, which poses significant risks for both mother and baby.
\n \n\n\n \n 28 February 2022\n \n
\n\n \n \n \n\n \n \n \nDraft guidelines to help improve practice when the state acts to safeguard a baby at birth have been created by researchers at Oxford (the Rees Centre) and Lancaster Universities - and are being tested across England and Wales.
\n \n\n\n \n 23 February 2022\n \n
\n\n \n \n \n\n \n \n \nA team of geneticists and archaeologists have analysed the fine-scale genetic structure and ancestry of nearly 1200 people from the United Arab Emirates (UAE), and found genetic traces of population mixing spanning thousands of years.
\n \n\n\n \n 21 February 2022\n \n
\n\n \n \n \n\n \n \n \nThe wide-ranging effects of Long COVID and the associated issues for healthcare providers have been revealed in a new review of the major studies into the condition, which specifically highlights the impact of Long COVID impact on the cardiovascular system.
\n \n\n\n \n 17 February 2022\n \n
\n\n \n \n \n\n \n \n \nINTERCOVID-2022: The University of Oxford is to launch the 2022 round of the global study to evaluate the effects of COVID-19 variants and vaccination in pregnancy.
\n \n\n\n \n 17 February 2022\n \n
\n\n \n \n \n\n \n \n \nMy colleagues behind the Oxford-Astra Zeneca vaccine, have shown what can be done in the face of a deadly global threat. By producing a world-saving vaccine in record time, they have not just saved millions of lives, they have been an inspiration to me and researchers around the world - both for their rapid action and their scientific achievement. We environmental scientists must do the same \u2013 in the face of an even bigger threat than COVID-19: climate change and biodiversity loss.\r\n\r\nBy Professor Nathalie Seddon, professor of biodiversity, director of the Nature-based Solutions Initiative.
\n \n\n\n \n 14 February 2022\n \n
\n\n \n \n \n\n \n \n \nThe University of Oxford's Professor Dame Sarah Gilbert has been named a Laureate of the 5th Sunhak Peace Prize for her efforts to protect global health during the COVID-19 pandemic.
\n \n\n\n \n 14 February 2022\n \n
\n\n \n \n \n\n \n \n \nClear messaging is key to any campaign, especially if you want people to behave in a certain way. Graphic images of damaged lungs have been put on packets of cigarettes, and you rarely see a role model lighting up. The message is clear: smoking is extremely bad for you. \r\n\r\nBy Professor Melinda Mills, Director of the Leverhulme Centre for Demographic Science at the University of Oxford. Professor Mills participates in multiple COVID advisory groups in the UK and European Commission but writes in a personal capacity.
\n \n\n\n \n 9 February 2022\n \n
\n\n \n \n \n\n \n \n \nResearchers at Oxford University have implanted a novel closed-loop research platform for investigating the role of the pedunculopontine nucleus (PPN) \u2013 a brainstem nucleus \u2013 in Parkinson\u2019s-like Multiple Systems Atrophy (MSA).
\n \n\n